MR

Maulik Rameshbhai Savani

Active Director Director DIN 07783661
DIN 07783661 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value •••• Premium profile

About Maulik Rameshbhai Savani

Data last updated:

Maulik Rameshbhai Savani is a Director at Pushti Pharmachem Private Limited (since 2017). The company operates in Pharma. Pushti Pharmachem Private Limited reported revenue of ₹6.41 Cr (FY 2024).

DIN 07783661
Primary Designation Director
Industry Pharma
First Appointment 29 Apr 2017
Oldest Company Age 11 yrs
Largest company Pushti Pharmachem Private Limited · ₹6.41 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pushti Pharmachem Private Limited U24100MP2014PTC033598
Director29 Apr 20172014₹6.41 Cr (FY 2024)Active

Board colleagues of Maulik Rameshbhai Savani

NameDINCompanyDesignation
Dilip Lavjibhai Moradia06580411Pushti Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pushti Pharmachem Private Limited
Premium access

Shareholding and investment profile for Maulik Rameshbhai Savani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maulik Rameshbhai Savani

Maulik Rameshbhai Savani currently holds 1 directorship: Pushti Pharmachem Private Limited (Director, since 29 Apr 2017, revenue ₹6.41 Cr (FY 2024)).

Maulik Rameshbhai Savani was first appointed on 29 Apr 2017 as Director at Pushti Pharmachem Private Limited.

The current boards of Maulik Rameshbhai Savani's companies include Dilip Lavjibhai Moradia (Pushti Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available